The Relationship of Estrogen Changes With Sinonasal Symptoms and Disease in Women: A Scoping Review
- PMID: 40260735
- PMCID: PMC12353375
- DOI: 10.1002/lary.32199
The Relationship of Estrogen Changes With Sinonasal Symptoms and Disease in Women: A Scoping Review
Abstract
Objective: Rhinitis and chronic rhinosinusitis (CRS) are inflammatory-driven processes. Previous research has shown an influence of sex hormones on inflammatory processes, including asthma. The purpose of this scoping review was to assess the existing epidemiologic literature looking at the relationship of estrogen to sinonasal symptoms in women.
Data sources: PubMed and Embase were searched with "estrogen," "rhinitis," and "female," along with related terms.
Methods: All English language articles examining the relationship between estrogen changes and sinonasal symptoms in women were included; case reports were excluded. Data collected included hormonal exposure, presence of sinonasal symptoms, and the influence of hormonal exposure on symptoms.
Results: 57 studies were included. The literature suggests worsening of sinonasal outcomes with and throughout pregnancy. Early menarche (higher lifetime estrogen) may be associated with a higher rhinitis likelihood, which may also suggest a pro-inflammatory estrogen effect. The literature, however, also suggests menopause (low estrogen state) is associated with worse sinonasal outcomes. The literature examining oral contraceptives and hormone replacement therapy is overall too conflicting and limited to suggest any directionality. There are few studies on CRS or its outcomes.
Conclusion: The studies included in this review suggest a potential relationship between biological sex, sex hormones, and sinonasal outcomes, but the validity of the findings is limited due to the lack of rigorous and standardized study design. Given the growing evidence of the inflammatory-modulating effects of sex hormones, which form a pathophysiologic basis for this relationship, further research on the impact of sex hormones on sinonasal disease is required.
Keywords: allergy; estrogen; olfaction; rhinology; sinonasal disease.
© 2025 The Author(s). The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.
Conflict of interest statement
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Treatments for seizures in catamenial (menstrual-related) epilepsy.Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3. Cochrane Database Syst Rev. 2021. PMID: 34528245 Free PMC article.
-
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2. Cochrane Database Syst Rev. 2023. Update in: Cochrane Database Syst Rev. 2023 May 15;5:CD014908. doi: 10.1002/14651858.CD014908.pub3. PMID: 36622724 Free PMC article. Updated.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources